Literature DB >> 10417150

Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control.

G A Martins1, L Q Vieira, F Q Cunha, J S Silva.   

Abstract

We have previously shown that splenocytes from mice acutely infected with Trypanosoma cruzi exhibit high levels of nitric oxide (NO)-mediated apoptosis. In the present study, we used the gamma interferon (IFN-gamma)-knockout (IFN-gamma(-/-)) mice to investigate the role of IFN-gamma in modulating apoptosis induction and host protection during T. cruzi infection in mice. IFN-gamma(-/-) mice were highly susceptible to infection and exhibited significant reduction of NO production and apoptosis levels in splenocytes but normal lymphoproliferative response compared to the infected wild-type (WT) mice. Furthermore, IFN-gamma modulates an enhancement of Fas and Fas-L expression after infection, since the infected IFN-gamma(-/-) mice showed significantly lower levels of Fas and Fas-L expression. The addition of recombinant murine IFN-gamma to spleen cells cultures from infected IFN-gamma(-/-) mice increased apoptosis levels, Fas expression, and NO production. In the presence of IFN-gamma and absence of NO, although Fas expression was maintained, apoptosis levels were significantly reduced but still higher than those found in splenocytes from uninfected mice, suggesting that Fas-Fas-L interaction could also play a role in apoptosis induction in T. cruzi-infected mice. Moreover, in vivo, the treatment of infected WT mice with the inducible nitric oxide synthase inhibitor aminoguanidine also led to decreased NO and apoptosis levels but not Fas expression, suggesting that IFN-gamma modulates apoptosis induction by two independent and distinct mechanisms: induction of NO production and of Fas and Fas-L expression. We suggest that besides being of crucial importance in mediating resistance to experimental T. cruzi infection, IFN-gamma could participate in the immune response control through apoptosis modulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417150      PMCID: PMC96666     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Different susceptibility of three clinically isolated strains of Cryptococcus neoformans to the fungicidal effects of reactive nitrogen and oxygen intermediates: possible relationships with virulence.

Authors:  Q Xie; K Kawakami; N Kudeken; T Zhang; M H Qureshi; A Saito
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

2.  Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine.

Authors:  L B Adams; J B Hibbs; R R Taintor; J L Krahenbuhl
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

Review 3.  Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells.

Authors:  P Minoprio; S Itohara; C Heusser; S Tonegawa; A Coutinho
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

4.  Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells.

Authors:  M Lepoivre; B Chenais; A Yapo; G Lemaire; L Thelander; J P Tenu
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

5.  Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection.

Authors:  M Rottenberg; C Lindqvist; A Koman; E L Segura; A Orn
Journal:  Scand J Immunol       Date:  1989-07       Impact factor: 3.487

6.  U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation.

Authors:  F Brockhaus; B Brüne
Journal:  Exp Cell Res       Date:  1998-01-10       Impact factor: 3.905

7.  Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes.

Authors:  J C Aliberti; M A Cardoso; G A Martins; R T Gazzinelli; L Q Vieira; J S Silva
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

8.  Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii.

Authors:  O Liesenfeld; J C Kosek; Y Suzuki
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

9.  A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis.

Authors:  J Estaquier; J C Ameisen
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

10.  Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus.

Authors:  G Stassi; R De Maria; G Trucco; W Rudert; R Testi; A Galluzzo; C Giordano; M Trucco
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more
  24 in total

Review 1.  Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection.

Authors:  L Cristina Gavrilescu; Eric Y Denkers
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium.

Authors:  Renu Dudani; Kaja Murali-Krishna; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

3.  Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.

Authors:  Ki-Man Kang; Gye-Sung Lee; Jae-Ho Lee; In-Wook Choi; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2004-12       Impact factor: 1.341

4.  Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation.

Authors:  I S Leal; B Smedegård; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

5.  Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).

Authors:  Rama Krishna Gurram; Weshely Kujur; Sudeep K Maurya; Javed N Agrewala
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

6.  Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis.

Authors:  Mathieu-Benoît Voisin; Dominique Buzoni-Gatel; Daniel Bout; Florence Velge-Roussel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Expression of cytokines and chemokines and microvasculature alterations of the tongue from patients with chronic Chagas' disease.

Authors:  Sanivia A de Lima Pereira; Viviane O Severino; Narayane L M Kohl; Denise B R Rodrigues; Polyanna M Alves; Juliana T Clemente-Napimoga; Marlene A dos Reis; Vicente P A Teixeira; Marcelo H Napimoga
Journal:  Parasitol Res       Date:  2009-06-10       Impact factor: 2.289

8.  Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.

Authors:  Ana-Carolina Oliveira; Bruna C de Alencar; Fanny Tzelepis; Weberton Klezewsky; Raquel N da Silva; Fabieni S Neves; Gisele S Cavalcanti; Silvia Boscardin; Marise P Nunes; Marcelo F Santiago; Alberto Nóbrega; Maurício M Rodrigues; Maria Bellio
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

9.  Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus.

Authors:  Nicole L Yates; Rama D Yammani; Martha A Alexander-Miller
Journal:  Virus Res       Date:  2008-08-23       Impact factor: 3.303

Review 10.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.